Elevated plasma advanced oxidation protein products in children with Henoch–Schonlein purpura


Henoch–Schonlein purpura (HSP) is a systemic vasculitis characterized by involvement of skin, joints, gastrointestinal tract (GIT), and kidney; its pathogenesis is still controversial. The aim of our study was to investigate the role of oxidative stress in the pathogenesis of HSP. Plasma advanced oxidation protein products (AOPP) level was measured in 29 children with HSP at the onset of the disease and during remission in comparison with 30 healthy subjects. Patients at the active stage had significantly higher AOPP levels than those at the remission stage of HSP and the controls (42.9 ± 25.7, 30.6 ± 11.8, 27.9 ± 11.2 mmol/l; P = 0.027 and P = 0.023 respectively). The mean AOPP levels of the patients with arthritis and/or arthralgia were significantly higher those than without joint involvement (48.3 ± 26.0 and 22.3 ± 9.3, P = 0.036 respectively). However, AOPP levels were similar in patients with and without gastrointestinal involvement. Plasma AOPP levels were positively correlated with leukocyte and thrombocyte count at disease onset, whereas they were found to be negatively correlated with serum glucose and sodium levels. The mean thrombocyte count was the only independent predictor of increased level of AOPP in regression analysis (β = 0.407; P = 0.029). In conclusion, this study showed that increased oxidative stress may play an important role in the pathogenesis of HSP. Also, we suggest that higher platelet count might be an indirect indicator of oxidative stress in these patients. Further research is required to identify the potential association between oxidative stress and increased thrombocyte count in children with HSP.

This is a preview of subscription content, access via your institution.


  1. 1.

    Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. II. Final classification criteria. Ann Rheum Dis 69:798–806

    Article  Google Scholar 

  2. 2.

    Skvarilová M, Bulava A, Stejskal D, Adamovská S, Bartek J (2005) Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149:83–87

    Article  Google Scholar 

  3. 3.

    Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C (2003) Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18:1272–1280

    CAS  Article  Google Scholar 

  4. 4.

    Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82:291–295

    CAS  Article  Google Scholar 

  5. 5.

    Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49(5):1304–1313

    CAS  Article  Google Scholar 

  6. 6.

    Buyan N, Erbas D, Akkok N, Oz E, Biberoğlu G, Hasanoğlu E (1998) Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch–Schonlein Purpura. Prostaglandins Leukot Essent Fatty Acids 59:181–184

    CAS  Article  Google Scholar 

  7. 7.

    Shah SV (1988) Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol 254:337–344

    Google Scholar 

  8. 8.

    Rahman MA, Emancipator SS, Sedor JR (1988) Hydroxyl radical scavengers ameliorate proteinuria in rat immune complex glomerulonephritis. J Lab Clin Med 112:619–626

    CAS  PubMed  Google Scholar 

  9. 9.

    Demircin G, Öner A, Ünver Y, Bülbül M, Erdoğan Ö (1998) Erythrocyte superoxide dismutase activity and plasma malondialdehyde levels in children with Henoch-Schönlein purpura. Acta Paediatr 87:848–852

    CAS  Article  Google Scholar 

  10. 10.

    Pryor WA (1986) Oxy-radicals and related species: their formation, lifetimes, and reactions. Annu Rev Physiol 48:657–667

    CAS  Article  Google Scholar 

  11. 11.

    Erdoğan Ö, Öner A, Aydın A, Işimer A, Demircin G, Bülbül M (2003) Effect of vitamin E treatment on the oxidative damage occurring in Henoch–Schönlein purpura. Acta Paediatr 92:546–550

    Article  Google Scholar 

  12. 12.

    Ece A, Kelekçi S, Kocamaz H, Hekimoğlu A, Balik H, Yolbaş I, Erel O (2008) Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura. Clin Rheumatol 27:163–169

    Article  Google Scholar 

  13. 13.

    Chen T, Guo ZP, Zhang YH, Gao Y (2009) Elevated serum xanthine oxidase activities in patients with Henoch-Schönlein purpura. Clin Rheumatol 28:1355–1356

    CAS  Article  Google Scholar 

  14. 14.

    Yilmaz A, Emre S, Agachan B, Bilge I, Yilmaz H, Ergen A, Isbir T, Sirin A (2009) Effect of paraoxonase 1 gene polymorphisms on clinical course of Henoch-Schönlein purpura. J Nephrol 22:726–732

    PubMed  Google Scholar 

  15. 15.

    Lin SJ, Huang JL, Hsieh KH (1998) Clinical and laboratory correlation of acute Henoch-Schönlein purpura in children. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 39:94–98

    CAS  PubMed  Google Scholar 

  16. 16.

    Maugeri N, Baldini M, Rovere-Querini P, Maseri A, Sabbadini MG, Manfredi AA (2009) Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: a clue to thromboembolic risks? Autoimmunity 42:386–388

    CAS  Article  Google Scholar 

  17. 17.

    Straface E, Gambardella L, Metere A, Marchesi A, Palumbo G, Cortis E, Villani A, Pietraforte D, Viora M, Malorni W, Del Principe D (2010) Oxidative stress and defective platelet apoptosis in naive patients with Kawasaki disease. Biochem Biophys Res Commun 392:426–430

    CAS  Article  Google Scholar 

  18. 18.

    Tian X, He XL, Fang YB, Zou RY (2009) Roles of platelet and its regulating factors in immune vasculitis in young rabbits. Zhongguo Dang Dai Er Ke Za Zhi 11:850–853

    CAS  PubMed  Google Scholar 

  19. 19.

    Dolezalová P, Telekesová P, Nemcová D, Hoza J (2002) Soluble adhesion molecules ICAM-1 and E-selectin in juvenile arthritis: clinical and laboratory correlations. Clin Exp Rheumatol 20:249–254

    PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Mahmut Civilibal.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Keskin, N., Civilibal, M., Elevli, M. et al. Elevated plasma advanced oxidation protein products in children with Henoch–Schonlein purpura. Pediatr Nephrol 26, 1989–1993 (2011). https://doi.org/10.1007/s00467-011-1905-y

Download citation


  • Henoch–Schonlein purpura
  • Children
  • Advanced oxidation protein product
  • Oxidative stress
  • Protein oxidation